US Stock MarketDetailed Quotes

LLY Eli Lilly and Co

Watchlist
  • 915.010
  • +13.210+1.46%
Close Feb 26 16:00 ET
  • 914.500
  • -0.510-0.06%
Post 16:21 ET
867.59BMarket Cap78.14P/E (TTM)

About Eli Lilly and Co Company

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Company Profile

SymbolLLY
Company NameEli Lilly and Co
Listing DateApr 1, 1973
Founded1876
CEOMr. David A. Ricks
MarketNYSE
Employees47000
Fiscal Year Ends12-31
AddressLilly Corporate Center
CityIndianapolis
ProvinceIndiana
CountryUnited States of America
Zip Code46285
Phone1-317-276-2000
Websitehttp://www.lilly.com

Company Executives

  • Name
  • Position
  • Salary
  • David A. Ricks
  • Chairman of the Board, President and Chief Executive Officer
  • 26.57M
  • Donald A. Zakrowski
  • Senior Vice President, Finance and Chief Accounting Officer
  • --
  • Diogo Rau
  • Executive Vice President, Chief Information Officer and Chief Digital Officer
  • --
  • Eric Dozier
  • Executive Vice President and Chief People Officer
  • --
  • Lucas Montarce
  • Executive Vice President and Chief Financial Officer
  • --
  • Dr. Daniel M. Skovronsky, M.D.
  • Executive Vice President, Chief Scientific Officer and President, Lilly Research Laboratories and Lilly Immunology
  • 11.85M
  • Ilya Yuffa
  • Executive Vice President; President, Lilly International
  • --
  • Anat Hakim
  • Executive Vice President, General Counsel and Secretary
  • 7.01M
  • Jacob S. Van Naarden
  • Executive Vice President and President, Lilly Oncology
  • 4.89M
  • Edgardo Hernandez
  • Executive Vice President and President, Manufacturing Operations
  • --
  • Anne E. White
  • Executive Vice President and President, Lilly Neuroscience
  • --
  • Patrik Jonsson
  • Executive Vice President and President, Lilly Cardiometabolic Health; President, Lilly USA
  • --
  • Melissa Seymour
  • Executive Vice President, Global Quality
  • --
  • Ralph Alvarez
  • Independent Director
  • 336.00K
  • Jon R. Moeller
  • Independent Director
  • --
  • Dr. Mary Lynne Hedley,PhD
  • Independent Director
  • 319.00K
  • Dr. Katherine Baicker, PhD
  • Independent Director
  • 336.00K
  • Juan R. Luciano
  • Lead Independent Director
  • 373.00K
  • Dr. William G. Kaelin, Jr
  • Independent Director
  • 349.15K
  • Jamere Jackson
  • Independent Director
  • 345.00K
  • Jon Erik Fyrwald
  • Independent Director
  • 344.88K
  • Kimberly H. Johnson
  • Independent Director
  • 316.00K
  • Gabrielle Sulzberger, J.D.,M.B.A.
  • Independent Director
  • 335.50K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
CG MED EQUIP.
838810
+29.94%
SUZHOUBEARING
430418
+22.35%
4
COCYBER
835207
+21.31%
5
Guangdong Create Century Intelligent Equipment Group Corporation
300083
+20.05%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.